Jump to Navigation
Activate excellence. Activate innovation. Activate success.
Aquinox Pharmaceuticals
Committed to the discovery, development, and commercialization of novel and targeted small molecule therapeutics for the treatment of inflammatory disease and cancer.
Corporate
Technology
News and Media
Careers
Contact Us
News
April 3, 2013
Aquinox Pharmaceuticals Completes US $18 Million Series C Financing
November 10, 2011
Aquinox Pharmaceuticals Initiates Two Phase IIa Clinical Studies in Airway Inflammation Following Successful Phase I